Company Filing History:
Years Active: 2015
Title: Willemjin Maria Gommans: Innovator in miRNA Therapeutics
Introduction
Willemjin Maria Gommans is a notable inventor based in Voorschoten, Netherlands. She has made significant contributions to the field of molecular biology, particularly in the area of miRNA therapeutics. Her innovative work focuses on the diagnostic and therapeutic applications of miRNA molecules in diseases associated with epithelial to mesenchymal transition (EMT).
Latest Patents
Willemjin holds a patent for a miRNA molecule defined by its source and its diagnostic and therapeutic uses in diseases or conditions associated with EMT. The invention relates to the diagnostic and therapeutic uses of a miRNA molecule or an equivalent thereof, wherein the source of said miRNA molecule comprises at least 80 nucleotides and includes a motif with at least 98% identity to the motif represented by SEQ ID NO:1. This groundbreaking work has the potential to advance treatment options for various conditions linked to EMT.
Career Highlights
Willemjin is currently associated with Interna Technologies B.V., where she continues to develop her research and innovations. Her work has garnered attention in the scientific community, contributing to advancements in therapeutic strategies.
Collaborations
Willemjin collaborates with esteemed colleagues, including Roeland Quirinus Jozef Schaapveld and Gerardus Wihelmus Christiaan Theodoor Verhaegh. These partnerships enhance her research and broaden the impact of her innovations.
Conclusion
Willemjin Maria Gommans is a pioneering inventor whose work in miRNA therapeutics is paving the way for new diagnostic and treatment methods. Her contributions are vital to the ongoing research in molecular biology and medicine.